Why the study?
Is red blood cell distribution width associated with multiple sclerosis and its disability status?
Population
109 patients with multiple sclerosis (MS) and 130 healthy individuals
Comparison
Subcutaneous recombinant IFN-β1a (Rebif) vs Healthy controls and treatment-naive MS patients
Design
Cohort
Authors
Loading...
RDW may mark MS-related inflammation; leaves open its value as biomarker or treatment monitor pending prospective studies.
Is red blood cell distribution width associated with multiple sclerosis and its disability status?
Elevated RDW is associated with multiple sclerosis and disability status, and decreases with IFN-β1a treatment.
Peng et al. (2015) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: